Quanterix Corporation Defined Contribution Plan, Cost
Quanterix Corporation (QTRX) reported Defined Contribution Plan, Cost of $2.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-03-02
- Quanterix Corporation defined contribution plan, cost for the quarter ending 2021-06-30 was $200.00K, a 0.00% change year-over-year.
- Quanterix Corporation defined contribution plan, cost for the quarter ending 2021-03-31 was $200.00K, a 100.00% increase year-over-year.
- Quanterix Corporation defined contribution plan, cost for the quarter ending 2020-12-31 was $200.00K, a 100.00% increase year-over-year.
- Quanterix Corporation defined contribution plan, cost for the quarter ending 2020-09-30 was $200.00K, a 100.00% increase year-over-year.
- Quanterix Corporation defined contribution plan, cost for fiscal 2025 was $2.20M, a 8.33% decline from fiscal 2024.
- Quanterix Corporation defined contribution plan, cost for fiscal 2024 was $2.40M, a 200.00% increase from fiscal 2023.
- Quanterix Corporation defined contribution plan, cost for fiscal 2023 was $800.00K, a 33.33% decline from fiscal 2022.
- Quanterix Corporation defined contribution plan, cost for fiscal 2022 was $1.20M, a 9.09% increase from fiscal 2021.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 9 month | Defined Contribution Plan, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.20M 10-K · filed 2026-03-02 | |||
| 2024-12-31 | $2.40M 10-K · filed 2026-03-02 | |||
| 2023-12-31 | $800.00K 10-K · filed 2026-03-02 | |||
| 2022-12-31 | $1.20M 10-K · filed 2025-03-17 | |||
| 2021-12-31 | $1.10M 10-K/A · filed 2024-12-26 | |||
| 2021-06-30 | $200.00K 10-Q · filed 2021-08-05 | $400.00K 10-Q · filed 2021-08-05 | $600.00K derived: sum of 3 quarters · filed 2023-03-06 | $800.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $200.00K 10-Q · filed 2021-05-06 | $400.00K derived: sum of 2 quarters · filed 2023-03-06 | $600.00K derived: sum of 3 quarters · filed 2023-03-06 | $800.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $400.00K derived: sum of 2 quarters · filed 2023-03-06 | $600.00K derived: sum of 3 quarters · filed 2023-03-06 | $700.00K 10-K · filed 2023-03-06 |
| 2020-09-30 | $200.00K 10-Q · filed 2020-11-06 | $400.00K derived: sum of 2 quarters · filed 2021-08-05 | $500.00K 10-Q · filed 2020-11-06 | $600.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $200.00K 10-Q · filed 2021-08-05 | $300.00K 10-Q · filed 2021-08-05 | $400.00K derived: sum of 3 quarters · filed 2022-03-01 | $500.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $100.00K 10-Q · filed 2021-05-06 | $200.00K derived: sum of 2 quarters · filed 2022-03-01 | $300.00K derived: sum of 3 quarters · filed 2022-03-01 | $400.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $200.00K derived: sum of 2 quarters · filed 2022-03-01 | $300.00K derived: sum of 3 quarters · filed 2022-03-01 | $500.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $100.00K 10-Q · filed 2020-11-06 | $200.00K derived: sum of 2 quarters · filed 2020-11-06 | $400.00K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $100.00K 10-Q · filed 2020-08-04 | $300.00K 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | $100.00K 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $100.00K 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |